https://www.elsevier.es/en-revista-acta-otorrinolaringologica-espanola-402-articulo-epistaxis-dabigatran-new-non-vitamin-k-S2173573514001197
Epistaxis and Dabigatran, a New Non-Vitamin K Antagonist Oral Anticoagulant | Acta...
ObjectiveDabigatran is a new non-vitamin K antagonist (VKA) anticoagulant with anti-thrombin
vitamin k antagonist
https://www.cochrane.org/evidence/CD010555_prothrombin-complex-concentrate-reversal-vitamin-k-antagonist-treatment-bleeding-and-non-bleeding
Prothrombin complex concentrate for reversal of vitamin K antagonist treatment in bleeding and...
vitamin k antagonist
https://www.mja.com.au/journal/2018/208/1/impact-non-vitamin-k-antagonist-oral-anticoagulants-noacs-anticoagulation
The impact of non-vitamin K antagonist oral anticoagulants (NOACs) on anticoagulation therapy in...
NOACs could improve the convenience of anticoagulation therapy for patients in remote locations
https://www.cochrane.org/evidence/CD014678_what-are-benefits-and-harms-non-vitamin-k-antagonist-oral-anticoagulants-which-help-prevent-blood
What are the benefits and harms of non-vitamin K antagonist oral anticoagulants (which help to...